Funding Details
- Awarder
- Inbox
- Date Award
- June 30, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Iambic Therapeutics is a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform. The company has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinical stage with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs.
- Location
-
San Diego,
CA,
US
- Coinvestors
- Mubadala Capital, Exor Ventures, Qatar Investment Authority (QIA), Abingworth, Illumina Ventures, Nexus Venture Partners, Coatue, Tao Capital Partners
Links